Skip to content

Drug interactions

Mobocertinib + Secobarbital

Severity: Major

Mobocertinib and Secobarbital: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Barbiturates induce CYP3A4, which is the main metabolic pathway of mobocertinib. Reduced exposure may lead to loss of antitumor efficacy.

What this interaction means in plain words

Mobocertinib and Secobarbital can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

CYP3A4 induction by secobarbital accelerates mobocertinib metabolism and lowers plasma concentrations.

What to do

Avoid concurrent use and select a non-inducing alternative for sedation. Monitor tumor response if the combination cannot be avoided.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mobocertinib and Secobarbital, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Mobocertinib with Secobarbital?

MediHelp rates the interaction as major. Mobocertinib and Secobarbital can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Barbiturates induce CYP3A4, which is the main metabolic pathway of mobocertinib. Reduced exposure may lead to loss of antitumor efficacy.

How serious is the interaction between Mobocertinib and Secobarbital?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use and select a non-inducing alternative for sedation. Monitor tumor response if the combination cannot be avoided.

What other medicines interact with Secobarbital?

MediHelp also lists interactions of Secobarbital with, for example, Calcium / magnesium / potassium / sodium oxybates, Doravirine, Elbasvir / grazoprevir. The full list is on the Secobarbital page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in